WASHINGTON (MedPage Today) — More than a year after the Institute of Medicine issued a report calling for mandatory naps for medical residents, the organization responsible for implementing — or rejecting — the controversial recommendation has yet to make a decision.
No Comments »
Filed under: General Health News
Measures of quality of care and clinical outcomes improved significantly when diabetic patients in a large private health plan were treated by physicians receiving pay-for-performance incentives, researchers said.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A warning of a risk of progressive multifocal leukoencephalopathy has been added to the label for the multiple sclerosis drug natalizumab (Tysabri), the FDA announced.
No Comments »
Filed under: Pharmacy News
Solvay Pharmaceuticals, Inc. announced today that Phase IIIb data published in the January issue of Clinical Therapeutics confirm that CREON® (pancrelipase) Delayed-Release Capsules significantly improves a key measure of fat absorption in children aged 7-11 years who have exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF), EPI is a condition resulting from a deficiency [...]
No Comments »
Filed under: Pharmacy News
Gentium S.p.A. today announced that the abstract titled, “Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study,” has been awarded the Van Bekkum Award for the best abstract submitted to the physician’s program for the European Group for Blood and Marrow [...]
No Comments »
Filed under: Pharmacy News
BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime’s commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial [...]
No Comments »
Filed under: Pharmacy News
Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM)…
No Comments »
Filed under: Pharmacy News
Solvay Pharmaceuticals, Inc…
No Comments »
Filed under: Pharmacy News
Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical group and Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announce the launch by Ipsen in France of Decapeptyl(R) LP 22…
No Comments »
Filed under: Pharmacy News
PharmAthene, Inc…
No Comments »
Filed under: Pharmacy News
